Blue water vaccines announces partnership with abvacc for joint development of novel monkeypox and marburg vaccine candidates

Cincinnati, ohio, feb. 01, 2023 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or the “company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced a collaboration with abvacc, inc. (“abvacc”) for the joint development of vaccine candidates targeting monkeypox and marburg virus disease (“mvd”).
BWV Ratings Summary
BWV Quant Ranking